Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Share News (CIR)

  • There is currently no data for CIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Oryx International Builds 8% Holding In Circassia Pharmaceuticals

Tue, 03rd Dec 2019 18:28

(Alliance News) - Oryx International Growth Fund Ltd has taken an 8.0% stake in Circassia Pharmaceuticals PLC, the latter said on Tuesday.

Prior to the transaction, which occurred on November 22, Oryx did not have any shares in the pharmaceutical company.

Shares in Oxford-based Circassia closed 3.4% lower on Tuesday in London at 20.10 pence each.

By George Collard; georgecollard@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
2 Jun 2020 10:07

Circassia Signs Equity Finance Facility For Up To GBP5 Million

Circassia Signs Equity Finance Facility For Up To GBP5 Million

Read more
15 Apr 2020 11:32

Another Circassia Investor Agrees To Approve Termination Of Astra JV

Another Circassia Investor Agrees To Approve Termination Of Astra JV

Read more
14 Apr 2020 15:59

UK DIRECTOR DEALINGS SUMMARY: RHI Magnesita Chair Spends EUR8 Million

UK DIRECTOR DEALINGS SUMMARY: RHI Magnesita Chair Spends EUR8 Million

Read more
9 Apr 2020 11:23

UK WINNERS & LOSERS SUMMARY: Lockdowns Lift Just Eat Takeaway Orders

UK WINNERS & LOSERS SUMMARY: Lockdowns Lift Just Eat Takeaway Orders

Read more
9 Apr 2020 10:52

Circassia Wants To Terminate AstraZeneca Deal And Transfer Drug Rights

Circassia Wants To Terminate AstraZeneca Deal And Transfer Drug Rights

Read more
10 Jan 2020 15:52

CIP Merchant Capital Acquires 3.4% Stake In Circassia Pharmaceuticals

CIP Merchant Capital Acquires 3.4% Stake In Circassia Pharmaceuticals

Read more
9 Jan 2020 12:03

Circassia shares rise as it flags 'significant' revenue growth

(Sharecast News) - Respiratory disease-focussed pharmaceutical company Circassia Pharmaceuticals updated the market on its trading for the year ended 31 December on Thursday, announcing that it expected revenues for the year to fall in the mid-range of its previously issued guidance of between £60m and £65m.

Read more
9 Jan 2020 09:20

Circassia Pharmaceuticals Expects 2019 Revenue Growth; Names New CFO

Circassia Pharmaceuticals Expects 2019 Revenue Growth; Names New CFO

Read more
3 Jan 2020 14:41

Adams increases stake in Circassia

(Sharecast News) - Adams announced on Friday that, on 2 January, it purchased an additional 2,400,000 ordinary shares in Circassia on the AIM market, at an average price of 19p per share, for a total cash consideration of £0.46m.

Read more
3 Jan 2020 09:50

Adams Increases Stake In Circassia Pharmaceuticals

Adams Increases Stake In Circassia Pharmaceuticals

Read more
19 Dec 2019 16:44

Circassia shares plunge as its partner terminates agreement

(Sharecast News) - Specialty biopharmaceutical company Circassia Pharmaceuticals updated the market on its licensing agreement with BeyondAir, previously AIT Therapeutics, on Thursday.

Read more
19 Dec 2019 09:27

Circassia Pharmaceuticals Notes Terminated Agreement With BeyondAir

Circassia Pharmaceuticals Notes Terminated Agreement With BeyondAir

Read more
19 Dec 2019 08:38

LONDON MARKET OPEN: Listless Start To Trade; BoE To Keep Rates Steady

LONDON MARKET OPEN: Listless Start To Trade; BoE To Keep Rates Steady

Read more
19 Dec 2019 07:38

LONDON MARKET PRE-OPEN: Higher Call; Endeavour-Centamin Tussle Ongoing

LONDON MARKET PRE-OPEN: Higher Call; Endeavour-Centamin Tussle Ongoing

Read more
5 Dec 2019 10:47

Circassia Pharmaceuticals CEO Retires; Reiterates 2019 Guidance

Circassia Pharmaceuticals CEO Retires; Reiterates 2019 Guidance

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.